NEFL and Alzheimer disease: The correlation between peak-levels of Alzheimer disease biomarkers and the cognitive outcome assessments was rho = −0.22 to 0.18, while the correlations for NfL was rho = −0.32 to −0.20 (p < 0.01), Table 2.